Literature DB >> 22233765

L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.

Ying Peng1, Yanli Hu, Shaofeng Xu, Pingping Li, Jiang Li, Li Lu, Hongyan Yang, Nan Feng, Ling Wang, Xiaoliang Wang.   

Abstract

L-3-n-butylphthalide (L-NBP), an extract from seeds of Apium graveolens Linn (Chinese celery), has been shown to have neuroprotective effects on cerebral ischemic, vascular dementia and amyloid-β (Aβ)-induced animal models by inhibiting oxidative injury, neuronal apoptosis and glial activation, regulating amyloid-β protein precursor (AβPP) processing and reducing Aβ generation. The aim of the present study was to examine the effect of L-NBP on learning and memory in AβPP and presenilin 1 (PS1) double-transgenic AD mouse model (AβPP/PS1) and the mechanisms of L-NBP in reducing Aβ accumulation and tau phosphorylation. Twelve-month old AβPP/PS1 mice were given 15 mg/kg L-NBP by oral gavage for 3 months. L-NBP treatment significantly improved the spatial learning and memory deficits compared to the vehicle-treated AβPP/PS1 mice, whereas L-NBP treatment had no effect on cerebral Aβ plaque deposition and Aβ levels in brain homogenates. However, we found an L-NBP-induced reduction of tau hyperphosphorylation at Ser199, Thr205, Ser396, and Ser404 sites in AβPP/PS1 mice. Additionally, the expressions of cyclin-dependent kinase and glycogen synthase kinase 3β, the most important kinases involved in tau phosphorylation, were markedly decreased by L-NBP treatment. The effects of L-NBP on decreasing tau phosphorylation and kinases activations were further confirmed in neuroblastoma SK-N-SH cells overexpressing wild-type human AβPP695 (SK-N-SH AβPPwt). L-NBP shows promising candidate of multi-target neuronal protective agent for the treatment of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22233765     DOI: 10.3233/JAD-2011-111577

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  20 in total

1.  Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.

Authors:  Huang Huang; Sipei Nie; Min Cao; Charles Marshall; Junying Gao; Na Xiao; Gang Hu; Ming Xiao
Journal:  Age (Dordr)       Date:  2016-07-21

2.  L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Yu Zhang; Long-Jian Huang; Si Shi; Shao-Feng Xu; Xiao-Liang Wang; Ying Peng
Journal:  CNS Neurosci Ther       Date:  2016-07-20       Impact factor: 5.243

3.  L-3-n-butylphthalide improves cognitive impairment of APP/PS1 mice by BDNF/TrkB/PI3K/AKT pathway.

Authors:  Jing Xiang; Jie Pan; Fujun Chen; Linlin Zheng; Yue Chen; Shutao Zhang; Wanyu Feng
Journal:  Int J Clin Exp Med       Date:  2014-07-15

4.  Improvement of cerebral ischemia-reperfusion injury by L-3-n-butylphthalide through promoting angiogenesis.

Authors:  Ying Huang; Lishou Pan; Ting Wu
Journal:  Exp Brain Res       Date:  2020-11-12       Impact factor: 1.972

5.  CaMKIIα Signaling Is Required for the Neuroprotective Effects of Dl-3-n-Butylphthalide in Alzheimer's Disease.

Authors:  Bing-Qiu Li; Ling-Zhi Xu; Fang-Yu Li; Ying Li; Yu Zhao; Heng Zhang; Mei-Na Quan; Jian-Ping Jia
Journal:  Mol Neurobiol       Date:  2022-03-19       Impact factor: 5.590

6.  L-3-n-Butylphthalide Regulates Proliferation, Migration, and Differentiation of Neural Stem Cell In Vitro and Promotes Neurogenesis in APP/PS1 Mouse Model by Regulating BDNF/TrkB/CREB/Akt Pathway.

Authors:  Hui Lei; Yu Zhang; Longjian Huang; Shaofeng Xu; Jiang Li; Lichao Yang; Ling Wang; Changhong Xing; Xiaoliang Wang; Ying Peng
Journal:  Neurotox Res       Date:  2018-05-04       Impact factor: 3.911

Review 7.  Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease.

Authors:  Keshav Anand; Marwan Sabbagh
Journal:  Expert Opin Investig Drugs       Date:  2015-08-01       Impact factor: 6.206

8.  L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurite pathology in Alzheimer's disease mouse model and cultured hippocampal neurons.

Authors:  Longjian Huang; Jiaqi Lan; Jingshu Tang; Yuying Kang; Xinhong Feng; Lei Wu; Ying Peng
Journal:  Mol Neurobiol       Date:  2020-11-03       Impact factor: 5.590

9.  DL-3-n-butylphthalide ameliorates diabetes-associated cognitive decline by enhancing PI3K/Akt signaling and suppressing oxidative stress.

Authors:  Bei-Ni Wang; Cheng-Biao Wu; Zi-Miao Chen; Pei-Pei Zheng; Ya-Qian Liu; Jun Xiong; Jing-Yu Xu; Pei-Feng Li; Abdullah Al Mamun; Li-Bing Ye; Zhi-Long Zheng; Yan-Qing Wu; Jian Xiao; Jian Wang
Journal:  Acta Pharmacol Sin       Date:  2021-01-18       Impact factor: 6.150

10.  The attenuation effect of potassium 2-(1-hydroxypentyl)-benzoate in a mouse model of diabetes-associated cognitive decline: The protein expression in the brain.

Authors:  Wenwen Yu; Huajing Yin; Yingni Sun; Si Shi; Jiang Li; Xiaoliang Wang
Journal:  CNS Neurosci Ther       Date:  2022-04-20       Impact factor: 7.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.